Effect of introduction of intermittently scanned continuous glucose monitoring on glycaemic control in individuals living with type 2 diabetes mellitus treated with non‐insulin therapies—A randomised controlled trial

医学 糖尿病 苦恼 随机对照试验 胰岛素 置信区间 内科学 2型糖尿病 2型糖尿病 内分泌学 临床心理学
作者
Emmanuel Ssemmondo,Najeeb Shah,Milly Newham,Alan S. Rigby,Rosalyn Buckland,Harshal Deshmukh,Thozhukat Sathyapalan
出处
期刊:Diabetes, Obesity and Metabolism [Wiley]
标识
DOI:10.1111/dom.16116
摘要

Abstract Aims This pilot randomised controlled trial aimed to evaluate the effect of introducing isCGM on glycaemic control and diabetes distress in individuals with T2DM receiving non‐insulin therapies. Materials and Methods Forty adults with T2DM were randomised to either receive FreeStyle Libre 2 (Libre 2), an isCGM system, or FreeStyle Libre Pro iQ (Libre Pro) also known as ‘blinded’ CGM. Participants were followed for 12 weeks. The primary outcome was a fall in haemoglobin A1c (HbA1c) of ≥5.5 mmol/mol. Diabetes distress was assessed using the two‐item diabetes distress scale (DDS2). Results The median age was 59.5 years; 57.5% were male. Of the Libre 2 users, 53% achieved a ≥5.5 mmol/mol reduction in HbA1c compared to 35% in the Libre pro group ( p = 0.34). Compared to Libre Pro, the use of Libre 2 was associated with an improved time in range at 12 weeks of 18 percentage points (confidence interval 2–35, p = 0.028). Participants in the Libre 2 group exhibited a non‐significant reduction in HbA1c levels of 8 mmol/mol compared to the Libre Pro group after 12 weeks. However, no significant differences were observed in other CGM metrics or diabetes distress between the study groups. Conclusions The use of isCGM in individuals living with T2DM on non‐insulin therapy showed promise in improving glycaemic control, as evidenced by increased TIR, albeit without a significant reduction in HbA1c or impact on diabetes distress, suggesting this could be potentially beneficial in individuals with T2DM.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
KY完成签到,获得积分10
3秒前
4秒前
悦耳绝施完成签到,获得积分10
5秒前
丁真先生发布了新的文献求助10
5秒前
6秒前
7秒前
陈哟发布了新的文献求助10
8秒前
自信的谷南完成签到,获得积分10
8秒前
天天快乐应助jio大洁采纳,获得10
8秒前
屁王发布了新的文献求助10
9秒前
11秒前
11秒前
2028847955完成签到,获得积分10
11秒前
12秒前
wang_2发布了新的文献求助30
13秒前
后来发布了新的文献求助10
14秒前
冬己发布了新的文献求助10
14秒前
15秒前
15秒前
zhaoxin发布了新的文献求助10
18秒前
天真之桃完成签到,获得积分10
18秒前
sheh发布了新的文献求助10
20秒前
香蕉觅云应助科研通管家采纳,获得10
22秒前
司南应助科研通管家采纳,获得10
22秒前
爆米花应助科研通管家采纳,获得10
22秒前
星辰大海应助科研通管家采纳,获得10
23秒前
23秒前
Owen应助科研通管家采纳,获得10
23秒前
科研通AI2S应助科研通管家采纳,获得10
23秒前
23秒前
tuanheqi应助xiaofei666采纳,获得50
23秒前
23秒前
23秒前
23秒前
25秒前
25秒前
monere应助lyn采纳,获得10
25秒前
26秒前
27秒前
高分求助中
The late Devonian Standard Conodont Zonation 2000
Nickel superalloy market size, share, growth, trends, and forecast 2023-2030 2000
The Lali Section: An Excellent Reference Section for Upper - Devonian in South China 1500
Smart but Scattered: The Revolutionary Executive Skills Approach to Helping Kids Reach Their Potential (第二版) 1000
Very-high-order BVD Schemes Using β-variable THINC Method 830
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 800
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 800
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3247794
求助须知:如何正确求助?哪些是违规求助? 2891053
关于积分的说明 8265876
捐赠科研通 2559283
什么是DOI,文献DOI怎么找? 1388075
科研通“疑难数据库(出版商)”最低求助积分说明 650683
邀请新用户注册赠送积分活动 627577